Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
- PMID: 33524539
- PMCID: PMC7846462
- DOI: 10.1016/j.phrs.2021.105473
Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
Figures



Comment on
-
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study.Pharmacol Res. 2020 Sep;159:104965. doi: 10.1016/j.phrs.2020.104965. Epub 2020 May 29. Pharmacol Res. 2020. PMID: 32474087 Free PMC article.
Similar articles
-
The effect of current antithrombotic therapy on mortality in nursing home residents with COVID-19: a multicentre retrospective cohort study.Age Ageing. 2024 May 1;53(5):afae094. doi: 10.1093/ageing/afae094. Age Ageing. 2024. PMID: 38748450 Free PMC article.
-
[Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug)].Nihon Rinsho. 1993 Nov;51 Suppl:179-85. Nihon Rinsho. 1993. PMID: 8283663 Review. Japanese. No abstract available.
-
Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.Br J Hosp Med. 1992 May 20-Jun 2;47(10):731-7. Br J Hosp Med. 1992. PMID: 1606457 Review.
-
Antithrombotic Medication and the Risk of Vitreous Hemorrhage in Atrial Fibrillation: Korean National Health Insurance Service National Cohort.Yonsei Med J. 2019 Jan;60(1):65-72. doi: 10.3349/ymj.2019.60.1.65. Yonsei Med J. 2019. PMID: 30554492 Free PMC article.
-
Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study.Gut. 2021 Oct;70(10):2012-2013. doi: 10.1136/gutjnl-2020-323668. Epub 2020 Dec 4. Gut. 2021. PMID: 33277346 No abstract available.
Cited by
-
Interaction effects between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and steroid or antiviral therapies in COVID-19: A population-based study.J Med Virol. 2021 May;93(5):2635-2641. doi: 10.1002/jmv.26904. Epub 2021 Mar 9. J Med Virol. 2021. PMID: 33638553 Free PMC article. No abstract available.
-
Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis.Front Pharmacol. 2022 Oct 5;13:989903. doi: 10.3389/fphar.2022.989903. eCollection 2022. Front Pharmacol. 2022. PMID: 36278186 Free PMC article.
-
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis.Front Cardiovasc Med. 2021 Oct 21;8:747620. doi: 10.3389/fcvm.2021.747620. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34746262 Free PMC article.
-
Frequency and Association of Polymorphisms in F2, F7, and PROS1 Coagulation Genes with Disease Severity in Coronavirus Disease 2019.Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241295731. doi: 10.1177/10760296241295731. Clin Appl Thromb Hemost. 2024. PMID: 39497411 Free PMC article.
-
Gender- and Age-Specific Associations of Visit-to-Visit Blood Pressure Variability With Anxiety.Front Cardiovasc Med. 2021 May 7;8:650852. doi: 10.3389/fcvm.2021.650852. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34026870 Free PMC article.
References
-
- Paranjpe I., Fuster V., Lala A., Russak A.J., Glicksberg B.S., Levin M.A., Charney A.W., Narula J., Fayad Z.A., Bagiella E., Zhao S., Nadkarni G.N. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients With COVID-19. J. Am. Coll. Cardiol. 2020;76(1):122–124. - PMC - PubMed
-
- Zhou J., Wang X., Lee S., Wu W.K.K., Cheung B.M.Y., Zhang Q., Tse G. Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score matched territory-wide study. Gut. 2020 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical